DAMONA Pharmaceuticals Appoints John Reilly as Chief Executive Officer
http://damonapharma.com/wp-content/uploads/2023/06/DAMONA-John-Reilly-CEO.png
1200
627
Thomas Prevot
http://1.gravatar.com/avatar/441964589afd9a17fb378ee0cd8d1fed?s=96&d=mm&r=g
TORONTO, June 13, 2023— DAMONA Pharmaceuticals, a preclinical biopharmaceutical company focused on the discovery and development of first-in-class small molecules for the treatment and prevention of cognitive symptoms associated with brain disorders and aging, today announced the appointment of John Reilly as the company’s Chief Executive Officer and member of the Board of Directors. Mr.…
read more